enVVeno Medical Corporation
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
(0.0% 1d) (-16.4% 1m) (8.8% 1y) (0.0% 2d) (0.0% 3d) (-2.4% 7d) (0.36% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 61,924,050
https://www.hancockjaffe.com
Sec Filling | Patents | 19 employees
(US) Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
add to watch list Paper trade email alert is off
Press-releases
New Topline Efficacy Data from the enVVeno Medical VenoValve® Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 15:00) - hancockjaffe.com
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: -1.22%
H: 0.0%
C: -2.06%
venovalve symposium topline medical trial
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: -1.22%
H: 0.0%
C: -2.06%
symposium topline medical trial
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
Published: 2024-04-09 (Crawled : 13:00) - hancockjaffe.com
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 0.58%
H: 3.07%
C: -2.88%
commercial medical
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
Published: 2024-03-21 (Crawled : 17:00) - hancockjaffe.com
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 0.17%
H: 4.63%
C: 3.83%
medical
enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
Published: 2024-03-15 (Crawled : 13:30) - hancockjaffe.com
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 0.0%
H: 5.47%
C: 4.94%
medical
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve® Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - hancockjaffe.com
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 2.96%
H: 3.48%
C: -9.7%
enous2024 venovalve positive topline meeting trial today
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 2.96%
H: 3.48%
C: -9.7%
enous2024 positive topline meeting trial today
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 22:00) - hancockjaffe.com
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 4.17%
H: 0.46%
C: -0.31%
update medical financial results
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 2.59%
H: 15.53%
C: 7.18%
enous2024 topline meeting medical trial
enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium
Published: 2023-11-16 (Crawled : 17:00) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K
|
Manufacturing
|
| O: 0.42%
H: 3.16%
C: -6.32%
device venovalve symposium positive medical trial
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10